2-(3-Hydroxy-4-methoxyphenyl)ethyl 6-deoxy-alpha-L-mannopyranosyl-(1->3)-[beta-D-galactopyranosyl-(1->6)]-4-O-[(2E)-3-(4-hydroxy-3-methoxyphenyl)-2-propenoyl]-beta-D-glucopyranoside(CAS: 120406-37-3)

This compound requires adherence to both REACH regulations for European Union manufacturers and importers, which mandates registration, evaluation, and authorization of chemicals. Additionally, it must comply with GHS (Globally Harmonized System of Classification and Labelling of Chemicals) for hazardous substance classification. In the United States, it should follow FDA guidelines for food contact substances and EPA regulations for environmental protection.

In synthesis, commonly used alternatives include isomers with similar functional groups, such as 2-(3-hydroxyphenyl)ethyl derivatives. Alternative reagents like 4-hydroxy-3-methoxybenzaldehyde or other carboxylic acids can also be considered as substitutes depending on the specific reaction conditions and desired product properties.

The research trend for this compound is increasing, particularly in the development of novel antiviral and anti-inflammatory agents. Market demand is growing due to its potential biological activities, with a focus on exploring its efficacy in medicinal chemistry and pharmaceutical applications. However, further studies are needed to establish its safety and effectiveness.

Waste containing this compound should be collected in appropriate containers and incinerated under controlled conditions if it is considered hazardous. For non-hazardous waste, it can be disposed of in accordance with local regulations. Environmental precautions include proper labeling and handling to prevent contamination of soil and water. Professional waste disposal services are recommended to ensure compliance with environmental protection standards.